Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Medicago appoints new CFO
Pierre Labbe was most recently vice president and CFO of Plexmar Resources. Prior to Plexmar, Mr Labbe spent three years as vice president, CFO and secretary of Medicago.
Pierre Labbe was most recently vice president and CFO of Plexmar Resources. Prior to Plexmar, Mr Labbe spent three years as vice president, CFO and secretary of Medicago.
ARC1779, a novel aptamer therapeutic agent, is indicated for the treatment of a rare, life-threatening blood disorder known as thrombotic thrombocytopenic purpura, or TTP. ARC1779 is currently in
This transaction is consistent with Simcere’s strategy to focus on first-to-market and innovative new drugs and expand its anticancer product portfolio.
The round was led by Unilever Technology Ventures, Novartis Venture Funds, the ATDC Seed Capital Fund, as well as a number of private investors. Rafael Andino, founder of
Champix’s approval in Japan was based on a 12-week, randomized, double-blind, placebo-controlled study in Japanese smokers who wanted to quit smoking. The primary endpoint, the percentage of subjects
Colistimethate for Injection, USP, 150mg is generic equivalent of JHP Pharmaceuticals’s Coly-Mycin M parenteral. APP has immediately commenced marketing and shipping the product. APP’s colistimethate is AP-rated, bar-coded
The US and EU trials each consist of two study groups; patients who received the graft/Vascular Wrap combination, and patients who received the graft alone. At the onset
The roll-over study will be open to patients who complete one of the two concurrent Phase III Capacity studies of pirfenidone in idiopathic pulmonary fibrosis (IPF). InterMune expects
This Phase II clinical trial is designed as a double-blind, placebo controlled trial that would evaluate safety and efficacy of oral flupirtine versus placebo in fibromyalgia patients. The
Some of the specific technology licensed includes the ERCC1 and RRM1 genes. Researchers at the University of South Florida have discovered a correlation between expression of ERCC1 (excision